Computer-aided detection and radiation therapy firm iCAD said that positive data involving its Xoft Axxent electronic brachytherapy system for the treatment of nonmelanoma skin cancer is being presented at the American Brachytherapy Society annual meeting this week in New Orleans.
The poster presentation from Dr. Ajay Bhatnagar of the University of Pittsburgh shares clinical outcomes data on 172 patients with 247 nonmelanoma skin cancer lesions treated with high-dose-rate electronic brachytherapy with surface applicators using the Xoft system. The data further demonstrate the system's effectiveness, according to iCAD.
